LD-2 disclosure · Registration
OBJECT PHARMA
Coverage · Registration filing — establishes the registrant/client relationship. No periodic income or expenses are reported at registration.
Client
- Name
- OBJECT PHARMA
- Description
- Biopharma company
- Location
- California · United States of America
Registrant
- Location
- Alexandria, Virginia, United States of America
Lobbying activities
2 issuesHealth Issues
Issues related to the development of neurotoxin treatment for PTSD and other mental health related disorders in regards to veterans.
LobbyistsCLAY WHITE
Covered position (CLAY WHITE): Chief of Staff, Leg Director - Congressman Chris Stewart; Leg Director, Leg Asst - Congressman Jason Chaffetz
Veterans
Issues related to the development of neurotoxin treatment for PTSD and other mental health related disorders in regards to veterans.
LobbyistsCLAY WHITE
Covered position (CLAY WHITE): Chief of Staff, Leg Director - Congressman Chris Stewart; Leg Director, Leg Asst - Congressman Jason Chaffetz